Patient P-02478

Synthetic patientMETA-24 · Day 164 · 35–44 · M · baseline S19Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Improving

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Stable

Discontinuation risk

10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S19

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity-8
GI instability-7
Treatment adherence+5

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

93 min

stable · +3.1 vs previous 14 d

Sleep duration

Wearable

6.1 h

stable · -0.1 vs previous 14 d

Energy level

Daily log

5.7/10

stable · +0.0 vs previous 14 d

Steps

Wearable

9,328

stable · -56 vs previous 14 d

GI burden

Companion

24/100

worsening · +5.6 vs previous 14 d

Adherence

Companion

97.6 %

stable · +1.5 vs previous 14 d

Sleep quality

Wearable

44.4/100

worsening · -2.3 vs previous 14 d

Glucose, CGM daily mean

CGM

136 mg/dL

stable · +5.0 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 81 from the failing basin, 9 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +6.6
Protein
supporter · GI -3.8 next day

Main detractors to watch

Bacteroides fragilis elevated
hidden · steering -7.4
Low-HRV stretch
perturbation · steering -2.7
Dietary drift
perturbation · steering -2.6
Alcohol on dosing days
perturbation · steering -1.8

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.8supporter · 95%
Dietary fat load
+2.3no signal · 50%
Histamine load
+1.4no signal · 22%
Alcohol
-0.7no signal · 15%
Caffeine
-0.6no signal · 15%
Simple carbohydrates
-0.5no signal · 15%
Ultra-processed food
+0.4no signal · 15%
Insoluble fibre
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
Autonomic recovery ↑20
- WearableShort sleep window
Mucosal barrier integrity ↓10
- WearableSleep 6.1 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure

Microbiome

Shannon diversity 4.6 · butyrate capacity 49/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 55 ms
Sleep: 6.8 h
Steps: 10,043
Resting HR: 65 bpm

Daily log: GI score 24, nutritional resilience 60, adherence 98.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	45%	S01	AD-05	no change	79
P-02277	37%	S05	AD-05	improved	92
P-02282	38%	S01	BR-03	no change	88
P-02013	36%	S14	BR-03	no change	94
P-02193	37%	S11	CR-01	improved	87
P-02354	33%	S01	CR-01	improved	78
P-02565	47%	S09	DT-01	no change	79
P-02081	39%	S20	DT-01	no change	88
P-02462	35%	S12	DT-01	improved	65
P-02249	33%	S09	DT-01	improved	100
P-02337	33%	S18	DT-01	no change	100
P-02491	33%	S09	DT-01	no change	65